(-0.07%) 5 474.50 points
(-0.10%) 38 781 points
(-0.04%) 19 914 points
(0.21%) $80.50
(1.33%) $2.83
(0.22%) $2 334.10
(-0.17%) $29.34
(-0.23%) $968.70
(0.01%) $0.932
(-0.15%) $10.64
(0.07%) $0.788
(-1.87%) $86.79
Live Chart Being Loaded With Signals
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins...
Stats | |
---|---|
Šios dienos apimtis | 52 807 |
Vidutinė apimtis | 87 273 |
Rinkos kapitalizacija | 57.60M |
EPS | $-0.0697 ( Q1 | 2024-05-14 ) |
Kita pelno data | ( $-0.0700 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-7.04 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0290 (1.47%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-11 | Buckland Barry | Buy | 11 793 | Common Stock |
2024-06-11 | Buckland Barry | Sell | 11 793 | Restricted Stock Unit |
2024-06-11 | Buckland Barry | Sell | 11 792 | Restricted Stock Unit |
2024-05-21 | Tarnok Michael P. | Buy | 16 875 | Common Stock |
2024-05-21 | Tarnok Michael P. | Buy | 5 625 | Common Stock |
INSIDER POWER |
---|
74.42 |
Last 99 transactions |
Buy: 3 448 379 | Sell: 707 702 |
Tūris Koreliacija
Dyadic International Inc Koreliacija
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Dyadic International Inc Koreliacija - Valiuta/Žaliavos
Dyadic International Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $2.90M |
Bruto pelnas: | $922 957 (31.84 %) |
EPS: | $-0.240 |
FY | 2023 |
Pajamos: | $2.90M |
Bruto pelnas: | $922 957 (31.84 %) |
EPS: | $-0.240 |
FY | 2022 |
Pajamos: | $2.93M |
Bruto pelnas: | $807 110 (27.54 %) |
EPS: | $-0.330 |
FY | 2021 |
Pajamos: | $2.40M |
Bruto pelnas: | $459 393 (19.11 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.